These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35251840)

  • 1. Bullous Pemphigoid Associated With Pembrolizumab Therapy for Non-Small-Cell Lung Cancer: A Case Report.
    Chatterjee T; Rashid TF; Syed SB; Roy M
    Cureus; 2022 Jan; 14(1):e21770. PubMed ID: 35251840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bullous pemphigoid in elderly woman affected by non-small cell lung cancer treated with pembrolizumab: A case report and review of literature.
    Cosimati A; Rossi L; Didona D; Forcella C; Didona B
    J Oncol Pharm Pract; 2021 Apr; 27(3):727-733. PubMed ID: 32772795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous metastases at the sites of pembrolizumab-induced bullous pemphigoid lesions in a patient with melanoma.
    Ványai B; Chien YC; Beke L; Szabó IL; Péter Z; Steuer-Hajdu K; Várvölgyi T; Méhes G; Emri G
    Immunotherapy; 2022 Dec; 14(17):1377-1382. PubMed ID: 36475303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the clinical characteristics of pembrolizumab-induced bullous pemphigoid.
    Wang J; Hu X; Jiang W; Zhou W; Tang M; Wu C; Liu W; Zuo X
    Front Oncol; 2023; 13():1095694. PubMed ID: 36937423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case Report: A Rare Case of Pembrolizumab-Induced Bullous Pemphigoid.
    Zhang X; Sui D; Wang D; Zhang L; Wang R
    Front Immunol; 2021; 12():731774. PubMed ID: 34594337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy.
    Guan S; Zhang L; Zhang J; Song W; Zhong D
    Front Immunol; 2022; 13():1068978. PubMed ID: 36685586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laryngeal Mucous Membrane Pemphigoid as an Immune-related Adverse Effect of Pembrolizumab Treatment.
    Lagos-Villaseca A; Koshkin VS; Kinet MJ; Rosen CA
    J Voice; 2023 Jan; ():. PubMed ID: 36658034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Nivolumab-Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein-1/Programmed Death Ligand-1 Inhibitors and Recommendations for Diagnosis and Management.
    Lopez AT; Geskin L
    Oncologist; 2018 Oct; 23(10):1119-1126. PubMed ID: 30018132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-PD1 immune checkpoint inhibitor-induced bullous pemphigoid in metastatic melanoma and non-small cell lung cancer.
    Schwartzman G; Simpson MM; Jones R; Schiavone K; Coffman M; Meyerle J
    Cutis; 2020 Jun; 105(6):E9-E12. PubMed ID: 32716997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of drug-induced bullous pemphigoid secondary to immunotherapy treated with upadacitinib: A case report.
    Gresham LM; Kirchhof MG
    SAGE Open Med Case Rep; 2023; 11():2050313X231160926. PubMed ID: 36968984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Retrospective, Single-Institution Experience of Bullous Pemphigoid as an Adverse Effect of Immune Checkpoint Inhibitors.
    Shalata W; Weissmann S; Itzhaki Gabay S; Sheva K; Abu Saleh O; Jama AA; Yakobson A; Rouvinov K
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Rare Case of Bullous Pemphigoid Secondary to Checkpoint Inhibitor Immunotherapy: A Tense Situation.
    Wesolow JT; Jalali S; Clark LD
    Cureus; 2021 Jul; 13(7):e16169. PubMed ID: 34367779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory Bullous Pemphigoid in a Patient with Metastatic Lung Adenocarcinoma Treated with Pembrolizumab.
    Cardona AF; Ruiz-Patiño A; Zatarain-Barron ZL; Ariza S; Ricaurte L; Rolfo C; Arrieta O
    Case Rep Oncol; 2021; 14(1):386-390. PubMed ID: 33776733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucous Membrane Pemphigoid, Bullous Pemphigoid, and Anti-programmed Death-1/ Programmed Death-Ligand 1: A Case Report of an Elderly Woman With Mucous Membrane Pemphigoid Developing After Pembrolizumab Therapy for Metastatic Melanoma and Review of the Literature.
    Zumelzu C; Alexandre M; Le Roux C; Weber P; Guyot A; Levy A; Aucouturier F; Mignot-Grootenboer S; Caux F; Maubec E; Prost-Squarcioni C
    Front Med (Lausanne); 2018; 5():268. PubMed ID: 30320114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management [Formula: see text].
    Muntyanu A; Netchiporouk E; Gerstein W; Gniadecki R; Litvinov IV
    J Cutan Med Surg; 2021; 25(1):59-76. PubMed ID: 32746624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of bullous pemphigoid associated with PD-1 and PD-L1 inhibitors.
    Lopez AT; Khanna T; Antonov N; Audrey-Bayan C; Geskin L
    Int J Dermatol; 2018 Jun; 57(6):664-669. PubMed ID: 29630716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bullous pemphigoid induced by cancer immunotherapy].
    Giroud S; Chiticariu-Durr E
    Rev Med Suisse; 2020 Apr; 16(688):624-628. PubMed ID: 32239835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disproportionality analysis of bullous pemphigoid adverse events with PD-1 inhibitors in the FDA adverse event reporting system.
    Aggarwal P
    Expert Opin Drug Saf; 2019 Jul; 18(7):623-633. PubMed ID: 31088310
    [No Abstract]   [Full Text] [Related]  

  • 19. Bullous Pemphigoid as an Adverse Reaction to Pembrolizumab: Two Case Reports.
    Thomsen K; Diernaes J; Øllegaard TH; Spaun E; Vestergaard C
    Case Rep Dermatol; 2018; 10(2):154-157. PubMed ID: 30022934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pembrolizumab-induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient.
    Honigman AD; Lai F; Elakis J; Prall O; Goh M; McCormack C
    Clin Case Rep; 2019 Apr; 7(4):773-775. PubMed ID: 30997084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.